Chemical identity

Gliclazide EP Impurity E / Gliclazide BP Impurity E

CAS 1808087-53-7 · C15H19N3O3S

01Identity

Identifiers and names for this exact compound. Empty fields are left unassigned.

Lazychem IDLC-16205
PubChem CID125302923
NameGliclazide EP Impurity E / Gliclazide BP Impurity E
CAS RN1808087-53-7
Molecular formulaC15H19N3O3S
Molecular weight321.39 g/mol
IUPAC name1-[(4-Methylphenyl)sulfonyl]-3-(3,3a,4,6a-tetrahydrocyclopenta[c]pyrrol-2(1H)-yl)urea
InChIKeyAFTMPFJWAIDLME-OLZOCXBDSA-N

02Structure identifiers

2D structurePubChem CID 125302923
2D structure: Gliclazide EP Impurity E / Gliclazide BP Impurity E, CAS 1808087-53-7
Structure of Gliclazide EP Impurity E / Gliclazide BP Impurity E (CAS 1808087-53-7). LazyChem record. Source identity: PubChem CID 125302923. Confirm the identifiers before analytical use.Download structure image

Structure facts for this exact identity.

Molecular formulaC15H19N3O3S
InChIKeyAFTMPFJWAIDLME-OLZOCXBDSA-N
Ring count3
Defined stereocentres2
Unassigned stereocentres0
SMILESCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2C[C@@H]3CC=C[C@@H]3C2
InChIInChI=1S/C15H19N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h2-3,5-8,12-13H,4,9-10H2,1H3,(H2,16,17,19)/t12-,13+/m1/s1

03Stereochemistry

The published structure contains 2 defined and 0 unassigned tetrahedral stereocentres. The exact wedge-and-dash depiction is shown above.

Defined stereocentres22D structure
Unassigned stereocentres02D structure
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 4Before symmetry reduction

Published same-connectivity configurations

2 records

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04India status for this compound

These results apply only to this exact compound name and CAS number. Confirm the current official instruments before making a regulatory decision.

NDPS / RCSNOT FOUND IN REVIEWED ENTRIESCAS 1808087-53-7 was not found in the reviewed exact-identity entries. Generic, class, analogue, salt and isomer provisions were not evaluated.
SCOMETNOT FOUND IN REVIEWED CAS ENTRIESCAS 1808087-53-7 was not found in the reviewed exact-CAS mapping. Generic and analogue entries were not evaluated.

05Names and relationships

Associated parent compound

Gliclazide

View API and impurity family

Other names

  • Gliclazide EP Impurity E
  • Gliclazide BP Impurity E
  • 6,7-Dehydro Gliclazide
  • rel-4-Methyl-N-(((3aR,6aS)-3,3a,4,6a-tetrahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)benzenesulfonamide
  • Gliclazide 6,7-Dehydro
  • Benzenesulfonamide, 4-methyl-N-[[[(3aR,6aS)-3,3a,4,6a-tetrahydrocyclopenta[c]pyrrol-2(1H)-yl]amino]carbonyl]-, rel-
  • GLICLAZIDE IMPURITY E [EP IMPURITY]
  • 4-methyl-N-(((3aS,6aR)-3,3a,6,6a-tetrahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)benzenesulfonamide
  • Benzenesulfonamide, 4-methyl-N-[[[(3aR,6aS)-3,3a,4,6a-tetrahydrocyclopenta[c]pyrrol-2(1H)-yl]amino]carbonyl]-, rel- (ACI)
  • rel-4-Methyl-N-[[[(3aR,6aS)-3,3a,4,6a-tetrahydrocyclopenta[c]pyrrol-2(1H)-yl]amino]carbonyl]benzenesulfonamide (ACI)

Related records from the same parent family

06Documented history

Dated discovery, occurrence, use and issue claims are published only when a suitable primary or government source is available.

No dated history available

No verified discovery, first report, occurrence, use or issue event is currently available for this identity.

07Sources